| Literature DB >> 35433826 |
Weifen Zhu1, Ziming Zhang2, Weiwei Gui1, Zheng Shen3, Yixin Chen1, Xueyao Yin1, Li Liang4, Lin Li1.
Abstract
High-throughput sequencing and weighted gene co-expression network analysis (WGCNA) were used to identify susceptibility modules and genes in liver tissue for the hypoxic pulmonary arterial hypertension (PAH) animal model following intrauterine growth retardation (IUGR). A total of 5,000 genes were clustered into eight co-expression modules via WGCNA. Module blue was mostly significantly correlated with the IUGR-hypoxia group. Gene Ontology analysis showed that genes in the module blue were mainly enriched in the fatty acid metabolic process, lipid modification, and fatty acid catabolic process. The Kyoto Encyclopedia of Genes and Genomes enrichment analyses showed that the genes in module blue were mainly associated with fatty acid metabolism, PPAR signaling pathway, and biosynthesis of unsaturated fatty acids. In addition, the maximal clique centrality method was used to identify the hub genes in the subnetworks, and the obtained results were verified using real-time quantitative PCR. Finally, we identified that four genes including Cyp2f4, Lipc, Acadl, and Hacl1 were significantly associated with IUGR-hypoxia. Our study identified a module and several key genes that acted as essential components in the etiology of the long-term metabolic consequences in hypoxia PAH following IUGR.Entities:
Keywords: hypoxia; intrauterine growth retardation; metabolic dysfunction; pulmonary arterial hypertension; weighted gene co-expression network analysis
Year: 2022 PMID: 35433826 PMCID: PMC9008831 DOI: 10.3389/fmolb.2022.789736
Source DB: PubMed Journal: Front Mol Biosci ISSN: 2296-889X
FIGURE 1Flowchart of the experimental procedure.
The primer sequences of the hub genes.
| Gene | Sequence | Product |
|---|---|---|
| MAPK14 | Forward | GCTGGCTCGGCACACTGATG |
| Reverse | GCCCACGGACCAAATATCCACTG | |
| Fam126b | Forward | GAGCCTGTCTGCCACCAACTG |
| Reverse | GCCATTGCTCTGCCTGTCTCTAC | |
| Cyp2j10 | Forward | CGCTGCTGTCACCTTCCTGTTC |
| Reverse | TGGCTGCTTCACATCCAACTGG | |
| Hacl1 | Forward | CATGTTCGGTGTCGTAGGCATCC |
| Reverse | GCCGCTTGCTCATTCCTCATCC | |
| Acsm3 | Forward | CTGTCTGTCAACGGAAGGTTCTGG |
| Reverse | AAACACATGCTCCTTGGGTCCAC | |
| Cyp2j4 | Forward | AGAGCTTGCCTTGGAGAACAACTG |
| Reverse | GCGGTGCGTGACTGGAGAAAG | |
| STARD4 | Forward | CCTGCGGCTGGTTCTGTGTTC |
| Reverse | TGCTTGCCATTGCTGTGTCTACC | |
| ACSL5 | Forward | GGCATCATTCGGCGGAACAG |
| Reverse | TGCAGCCCTGAAGAACGTCA | |
| ACADVL | Forward | TGTGCTAGGAGAAGTGGGAGATGG |
| Reverse | TCAACCGCCTTGGCAATGATGG | |
| AGTR1a | Forward | GCTTCAACCTCTACGCCAGTGTG |
| Reverse | CGAGACTTCATTGGGTGGACGATG | |
| Cyp2f4 | Forward | TGTCATCTTCGGCAGTCGTTTCG |
| Reverse | CCAGGCACCCAGTCCAGGAG | |
| Acads | Forward | CTCACAGCAGAAGCAGCAGTGG |
| Reverse | TGCCGTTGAGGACCCAGGAG | |
| Lipc | Forward | AGGTGGCTGCTCTTCTCCTATGG |
| Reverse | GCTCCCAGGCTGTACCCAATTAAG | |
| ACAT1 | Forward | CAGACGTGGTGGTGAAGGAAGATG |
| Reverse | ATCGTTCAGTGTGCTGGCGTTAG | |
| Acadl | Forward | CCCTGGTTTCAGCCTCCATTCAG |
| Reverse | CACTTGCCCGCCGTCATCTG | |
| HADHA | Forward | GGTGTCTTGCTCCCATGATGTCAG |
| Reverse | GAAGCCGAAGCCTGTGGTCAAG | |
| ECI1 | Forward | CCGAGCGTGCCCTTCAACTG |
| Reverse | GCCATCACTGAGCGAGCCTTG | |
| GAPDH | Forward | GACAACTTTGGCATCGTGGA |
| Reverse | ATGCAGGGATGATGTTCTGG |
Notes: MAPK14, mitogen-activated protein kinase 14; Fam126b, family with sequence similarity 126 member B; Cyp2j10, cytochrome P450, family 2, subfamily j, polypeptide 10; Hacl1, 2-hydroxyacyl-CoA lyase 1; Acsm3, acyl-CoA synthetase medium-chain family member 3; Cyp2j4, cytochrome P450, family 2, subfamily j, polypeptide 4; STARD4, cytosolic StAR-related lipid transfer domain 4; ACSL5, acyl-CoA synthetase long-chain family member 5; ACADVL, acyl-CoA dehydrogenase, very long chain; AGTR1a, angiotensin type 1a receptors; Cyp2f4, cytochrome P450, family 2, subfamily f, polypeptide 4; Acads, acyl-Coenzyme A dehydrogenase; Lipc, Hepatic lipase; ACAT1, acetyl-coA acetyltransferase 1; Acadl, long chain acyl CoA dehydrogenase; HADHA, hydroxyacyl CoA dehydrogenase trifunctional multienzyme complex subunit alpha; ECI1, Enoyl-CoA Delta Isomerase 1; GAPDH, glyceraldehyde-3-phosphate dehydrogenase.
FIGURE 2Sample dendrogram and trait heatmap, and the estimation of soft thresholding values (β). (A) Sample cluster dendrogram and clinical trait heatmap of 20 liver samples based on their expression profile: five control-normoxia (Control-N), five IUGR-normoxia (IUGR-N), five control-hypoxia (Control-H), and five IUGR-hypoxia (IUGR-H). (B) Analysis of the scale-free fit index for various soft thresholding powers (β). (C) Analysis of mean connectivity of various soft thresholding powers.
FIGURE 3Division and validation of co-expression modules. (A) Cluster dendrogram of the identified co-expression modules. The identified modules were coded by colors indicated below the dendrogram. The upper one presents the first set of modules obtained from the dynamic tree cut algorithm, while the lower one presents the merged modules according to Pearson’s correlation analysis. (B) Network heatmap plot showing topological overlaps, with light colors denoting low adjacency and darker colors denoting higher adjacency.
FIGURE 4Identification and verification of clinical related modules. (A) Module–trait associations. Each row corresponds to a module eigengene, while each column corresponds to a trait. Each cell contained the correlation coefficients and p-value. (B) Scatterplot of gene significance (GS) vs. module membership (MM) in the blue module. The correlation coefficients and p-value are listed above the scatterplot.
FIGURE 5GO and KEGG enrichment analyses in the blue module. (A) Top 15 significantly enriched GO biological process (BP) terms. The depth of color corresponds to the enrichment significance of each term, while the x-axis represents the gene counts. (B) Top 15 significantly enriched KEGG terms. The depth of color corresponds to the enrichment significant of each term, while the size of the dots correlates with the enriched gene counts.
FIGURE 6Subnetworks based on maximal clique centrality values. (A) Subnetwork of the GO term “fatty acid metabolic process.” (B) Subnetwork of the GO term “lipid modification.” The red nodes (higher MCC value) and yellow nodes (lower MCC value) represent genes with the top 10 MCC values.
FIGURE 7Validation of the hub genes using qRT-PCR. (A) Expression of hub genes between the IUGR-normoxia and IUGR-hypoxia groups. (B) and (C) Validation of the hub genes using qRT-PCR. * p < 0.05, IUGR-normoxia vs. IUGR-hypoxia. ** p < 0.01, IUGR-normoxia vs. IUGR-hypoxia.